Measurement of Disease Activity in Ulcerative Colitis: Interobserver Agreement and Predictors of Severity

被引:37
作者
Thia, Kelvin T. [1 ,2 ]
Loftus, Edward V., Jr. [1 ]
Pardi, Darrell S. [1 ]
Kane, Sunanda V. [1 ]
Faubion, William A. [1 ]
Tremaine, William J. [1 ]
Schroeder, Kenneth W. [1 ]
Harmsen, Scott W. [3 ]
Zinsmeister, Alan R. [3 ]
Sandborn, William J. [1 ]
机构
[1] Mayo Clin, Miles & Shirley Fiterman Ctr Digest Dis, Rochester, MN USA
[2] Singapore Gen Hosp, Dept Gastroenterol & Hepatol, Singapore 0316, Singapore
[3] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA
关键词
ulcerative colitis; endoscopic evaluation; diagnosis; disease activity; INFLAMMATORY-BOWEL-DISEASE; ACTIVITY INDEX; OBSERVERS; THERAPY;
D O I
10.1002/ibd.21480
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Endoscopic evaluation plays a pivotal role in the assessment of treatment response in ulcerative colitis (UC). This study aimed to determine the interobserver agreement (IOA) for assessment of mucosal lesions, and to determine lesions predictive of global assessment of endoscopic severity (GAES). Methods: Fifty-one UC patients had digital videorecording of their colonoscopic examinations, edited into videoclips representative of five colonic segments (rectum, sigmoid, descending, transverse, ascending/cecum). Seven gastroenterologists specializing in inflammatory bowel disease (IBD) independently and blindly rated individual lesions and endoscopic severity for each segment and globally. Edema, erythema, stricture, loss of haustral folds, rigidity, and pseudopolyps were scored as absent or present while vascular pattern, granularity, ulceration, and bleeding-friability were scored using a predefined severity scale. The GAES was based on a 4-point scale and a 10-cm visual analog scale (VAS). The IOA among raters was estimated using Lin's concordance correlation coefficient (CCC). Strength of agreement was categorized as excellent (0.81-1.00), good (0.61-0.80), moderate (0.41-0.60), and fair (0.21-0.40). Linear regression analysis was used to identify lesions predictive of overall endoscopic severity and develop a scoring system for clinical use. Results: Granularity, vascular pattern, ulceration, bleeding/friability, and pseudopolyps had good IOA in most segments. There was excellent agreement for VAS and good agreement for GAES and the VAS was significantly associated with GAES (P < 0.001). Granularity, vascular pattern, ulceration, and bleeding-friability were significant predictors of overall endoscopic severity. Conclusions: Granularity, vascular pattern, ulceration, and bleeding-friability demonstrated good reproducibility and were predictors of the GAES in UC patients.
引用
收藏
页码:1257 / 1264
页数:8
相关论文
共 14 条
[1]   VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS [J].
BARON, JH ;
CONNELL, AM ;
LENNARDJONES, JE .
BRITISH MEDICAL JOURNAL, 1964, 1 (5374) :89-+
[2]   Estimating the generalized concordance correlation coefficient through variance components [J].
Carrasco, JL ;
Jover, L .
BIOMETRICS, 2003, 59 (04) :849-858
[3]   A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis [J].
D'Haens, Geert ;
Sandborn, William J. ;
Feagan, Brian G. ;
Geboes, Karel ;
Hanauer, Stephen B. ;
Irvine, E. Jan ;
Lemann, Marc ;
Marteau, Philippe ;
Rutgeerts, Paul ;
Scholmerich, Jurgen ;
Sutherland, Lloyd R. .
GASTROENTEROLOGY, 2007, 132 (02) :763-786
[4]   Inter-observer agreement in the assessment of endoscopic findings in ulcerative colitis [J].
de Lange, T ;
Larsen, S ;
Aabakken, L .
BMC GASTROENTEROLOGY, 2004, 4 (1)
[5]   Treatment of ulcerative colitis with a humanized antibody to the α4β7 integrin [J].
Feagan, BG ;
Greenberg, GR ;
Wild, G ;
Fedorak, RN ;
Paré, P ;
McDonald, JWD ;
Dubé, R ;
Cohen, A ;
Steinhart, AH ;
Landau, S ;
Aguzzi, RA ;
Fox, IH ;
Vandervoort, MK .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (24) :2499-2507
[6]   Mucosal healing in inflammatory bowel disease: Results from a Norwegian population-based cohort [J].
Froslie, Kathrine Frey ;
Jahnsen, Jorgen ;
Moum, Bjorn A. ;
Vatn, Morten H. .
GASTROENTEROLOGY, 2007, 133 (02) :412-422
[7]   A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis [J].
Levine, DS ;
Riff, DS ;
Pruitt, R ;
Wruble, L ;
Koval, G ;
Sales, D ;
Bell, JK ;
Johnson, LK .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (06) :1398-1407
[8]   Comparison of a disease activity index and patients' self-reported symptom severity in ulcerative colitis [J].
Maunder, RG ;
Greenberg, GR .
INFLAMMATORY BOWEL DISEASES, 2004, 10 (05) :632-636
[9]  
Orlandi F, 1998, ITAL J GASTROENTEROL, V30, P539
[10]  
RUTGEERTS P, 2005, GUT S7, V54, pA8